NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
NeuroPace's operating income for the twelve months ending Jun 30, 2026 was -$15.08M. For fiscal 2025 it was -$16.34M. The highest annual figure on record is -$13.05M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.34M | – |
| FY2024 | Dec 31, 2024 | -$21.67M | – |
| FY2023 | Dec 31, 2023 | -$27.17M | – |
| FY2022 | Dec 31, 2022 | -$40.79M | – |
| FY2021 | Dec 31, 2021 | -$23.74M | – |
| FY2020 | Dec 31, 2020 | -$13.05M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.14M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.57M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.23M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.55M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.85M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.86M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.97M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.02M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.24M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.45M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.46M | – |
See a number that looks wrong?